WANDA BEARING
920002
HENDERA
831152
LINGOOD
833284
WUHAN LAND
830779
TECHVISION
832876
CN Stock MarketDetailed Quotes
301112 United Faith Auto-Engineering
- 27.12
- -0.74-2.66%
Market Closed Feb 27 15:00 CST
2.99BMarket Cap366.49P/E (TTM)
27.80High26.44Low45.09KlotVolume27.50Open27.86Pre Close122.09MTurnover12.44%Turnover Ratio70.44P/E (Static)110.27MShares32.3852wk High2.44P/B983.29MFloat Cap17.4852wk Low33.43Limit Up36.26MShs Float62.86Historical High22.29Limit Down4.88%Amplitude15.18Historical Low0.12Dividend TTM27.08Avg Price23.46KlotAsk0.44%Div YieldTTM100Lot Size19.44KlotBid
United Faith Auto-Engineering News
Xinbang Asia Vets (301112.SZ): The company is making arrangements for collaborative robots in the field of Siasun Robot&Automation.
According to the IFR "2023 World Robotics Report" released on February 24, Globon Intelligent (301112.SZ) stated on the investor interaction platform that the annual compound growth rate of the Global industrial robot market is expected to reach 7% from 2023 to 2026. The company focuses on Siasun Robot&Automation, industrial robots, and related Asia Vets technologies, providing high-end equipment design and manufacturing integration for new quality productivity. Currently, the company is laying out collaborative robots in the robot field. The maturity of collaborative robot technology, scene adaptability, and cost-effectiveness meet the demands of current industrial scenarios, while humanoid robots are not applicable in this context.
Market Chatter: Independent Report Says Eight Chinese Firms Receive Warnings, Fine For Environmental Rule Violations
Xinbang Intelligence: 2024 Annual Performance Forecast
Xinbang Asia Vets (301112.SZ): Expected net income in 2024 to decrease by 82.32%-88.21% year-on-year.
On January 23, Gluonhui reported that Asia Vets Technology (301112.SZ) expects a net income of 5 million to -7.5 million yuan in 2024, a decrease of 88.21% to 82.32% compared to the same period last year. The non-recurring net income is also 5 million to 7.5 million yuan, down 78.53% to 67.79% year-on-year. 1. The company acquired 51% of Zhuhai Jingsheng Technology Co., Ltd. (hereinafter referred to as 'Jingsheng Technology') in 2023. Jingsheng Technology failed to achieve scaled production on schedule, and the operation during the reporting period did not meet expectations, with an anticipated loss of 2,600.
Xinbang Intelligence: Report for the third quarter of 2024
Xinbang Asia Vets (301112.SZ): net income of 8.6147 million yuan in the first three quarters, a year-on-year decrease of 79.92%.
Gelonghui October 28th | Xingbang Asia Vets (301112.SZ) announced its third quarter report for 2024, with the company achieving revenue of 0.433 billion yuan in the first three quarters, a year-on-year increase of 17.00%; net income attributable to shareholders of the listed company was 8.6147 million yuan, a year-on-year decrease of 79.92%; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 7.0746 million yuan, a year-on-year decrease of 68.28%; basic earnings per share were 0.08 yuan.
Asia Vets (301112.SZ): Proposed 0.47 million shares of the 2024 restricted stock incentive plan
Grondonghui September 20th | Trustbond Asia Vets (301112.SZ) announced the 2024 Restricted Stocks Incentive Plan (draft), which plans to grant 0.47 million restricted stocks to incentive recipients, accounting for approximately 0.43% of the company's total stock of 110.2666 million stocks as of the date of the announcement of this incentive plan draft. This grant is a one-time grant with no reserved rights. The grant price of the restricted stocks in this incentive plan is 9.78 yuan / stock. The incentive objects granted in this incentive plan total 38 people, including directors serving in the company (including subsidiaries) at the time of the announcement of this incentive plan.
Xinbang Intelligence: 2024 Semi-Annual Report
Xinbang Intelligence: 2024 Semi-Annual Report Summary
Xinbang Asia Vets (301112.SZ): The net loss in the first half of the year was 17.6055 million yuan.
On August 27th, Guangdong Brilliant's (301112.SZ) released its interim report for 2024, with operating revenue of 0.16 billion yuan, a year-on-year decrease of 39.32%. The net loss attributable to shareholders of listed companies was 17.6055 million yuan. The net loss attributable to shareholders of listed companies after deducting non-recurring gains and losses was 14.3898 million yuan. The basic loss per share was RMB 0.16.
Xinbang Asia Vets (301112.SZ) released its performance for the first half of the year, with a loss of 17.6055 million yuan after a profit.
Xinbang Asia Vets (301112.SZ) released its 2024 interim report, with revenue of 0.16 billion yuan...
Xinbang Asia Vets (301112.SZ): Currently, the company's new quality production equipment is applied to autos, aviation, eco-friendly concepts, new energy funds and other key development areas.
On August 9th, Gelunhui reported that Xinnuo Intelligent (301112.SZ) stated on the investor platform that it belongs to a new quality productivity enterprise. Compared with traditional productivity, new quality productivity features high technology, high efficiency, and high quality. In the field of advanced manufacturing, the new quality productivity equipment provided by the company can improve the production efficiency of traditional industries. Currently, the company's new quality productivity equipment is applied in various key development areas such as autos, aviation, eco-friendly concepts, and new energy funds. Regarding machine vision: the company's machine vision technology is not a branch of artificial intelligence, but adopts dual-engine processing (accurate classification through ADC+
Siasun Robot&Automation (301112.SZ) does not directly manufacture robot ontology.
Xinbang Intelligence (301112.SZ) stated on the investor platform on August 8th that the company is a high-end equipment design, manufacturing, and integration company with industrial robots, collaborative robots, and related intelligent technologies as its core. The company has strategic cooperation and joint research and development with individual head manufacturers of collaborative robots. The company does not directly produce the body of robots.
Senbang Asia Vets (301112.SZ): Commercial space is not the current development direction of the company.
On August 6, Gelunhui reported that InfoBeyond Intelligent (301112.SZ) stated on the investor interaction platform that the company is a high-end equipment design, manufacturing and integrated company with industrial robots, collaborative robots and related intelligent technologies as its core. It highly values the development of various cutting-edge advanced technologies, and timely carries out and lays out relevant work according to customer needs and market development. In the aviation field, the company conducts research and application of related technologies for high-precision automatic detection equipment of aviation key components, and commercial aerospace is not the company's current development direction.
For low-altitude economy, Xunbang Asia Vets (301112.SZ) has not yet implemented overall business deployment and specialized technical research and development.
Xinbang Asia Vets (301112.SZ) stated on the investor interaction platform on August 1st that the company is a high-end equipment design, manufacturing and integration company with industrial robots, collaborative robots and related intelligent technologies as its core. It attaches great importance to the development of various cutting-edge and advanced technologies, and timely carries out layout-related work in combination with customer needs, market development and other factors. As for the low-altitude economy, the company has not yet deployed overall business and special technical research and development.
A-share siasun robot&automation sector has been active repeatedly, with zhejiang founder motor up for three consecutive days.
On August 1, Founder Motor rose for three consecutive days, while Xingbang Intelligence rose for two consecutive days. Jiaxun Feihong, Dongfang Precision Science & Technology, Ningbo Zhongda Leader Intelligent Transmission, and China Leadshine Technology followed suit. In terms of news, the latest research report by Omdia predicts that the global shipment of humanoid robots will exceed 0.01 million units by 2027 and will reach 0.038 million units by 2030. This means that the compound annual growth rate from 2024 to 2030 will reach 83%.
Asiavet (301112.SZ): Aerospace is not the current direction of company development.
Siasun Robot&Automation (301112.SZ) stated on the investor interaction platform on July 29 that the company is a high-end equipment design, manufacturing and integration company focusing on industrial robots, cooperative robots and related intelligent technologies. The company attaches great importance to the development of various cutting-edge advanced technologies, and carries out relevant work in combination with customer needs, market development and other factors in a timely manner. In the aviation field, the company is currently mainly researching and applying the relevant technologies of automated testing equipment for key precision parts in the aviation field, and the aerospace field is not the current development direction of the company.
As of June 28th, Asia Vets (301112.SZ) has a total of 13,920 registered shareholders.
On July 8th, Gelunhui reported that as of June 28th, 2024, there were a total of 13,920 registered shareholders in Asiavet (301112.SZ) according to the investor interaction platform.
Express News | Siasun Robot&Automation sector rose in early trading, and Xunbang Intelligence rose by the limit of 20CM.
Sinbond Intelligence (301112.SZ): Does not involve the production and manufacturing of humanoid robot parts or mechanical dog parts.
On June 17th, Gelonhui reported that XINBANG Intelligence (301112.SZ) stated on their investor communication platform that the company is a high-end equipment design and manufacturing integrated company with industrial robots, collaborative robots, and related intelligent technology as the core, and does not involve the production and manufacturing of humanoid robot parts or mechanical dog parts.
